PhD, EPA, CPA, FRSC, Vice President, Strategy & Operations, Head of Intellectual Property
Michelle Jones joined Astex in 2000. She is involved in corporate matters, research portfolio planning and strategic alignment of the business.
Michelle is also Head of IP, handling a global portfolio of preclinical, clinical and marketed pharmaceutical compounds. Michelle is experienced in a wide range of areas of patent practice, as well as freedom-to-operate and IP license strategies. She has extensive experience of IP due diligence activities to support collaboration and licensing initiatives, external fund-raising and investment decisions as well as involvement in research collaboration agreement negotiations.
Michelle is a European and Chartered (UK) Patent Attorney. She is Vice-Chair of the BioIndustry Association IP Advisory Committee, member of the CIPA Life Science Committee and Fellow of the Royal Society of Chemistry. Michelle obtained a B.Sc.(Hons) from University of Birmingham and Ph.D. from University of Cambridge.
Michelle has been recognised in the 2019 and 2020 editions of IAM Strategy 300: The World’s Leading IP Strategists, an annual list of individuals who lead the way in the development and implementation of strategies that maximise the value of IP portfolios. In 2020 she was also named a Managing IP Corporate IP Star, which recognises in-house practitioners for their contributions to the protection and management of their company’s IP assets and/or influence in the IP community.